Iran has begun mass production of its own COVID-19 COVIRAN vaccine, Interfax reported.

The trials of this vaccine are in the third stage, but it has already begun to be administered to volunteers. 

It is planned to produce more than 30 million doses of the COVIRAN vaccine by September, including 1 million doses in May, 3.5 million in June, 12 million in July and 15 million in August.